Auxly Cannabis Group Inc. (XLY.TO)
CAD 0.09
(0.0%)
CAD 0.09
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -19 Million CAD | 9.91% |
| 2022 | -46.79 Million CAD | -11.39% |
| 2021 | -42 Million CAD | 22.25% |
| 2020 | -54.03 Million CAD | 11.49% |
| 2019 | -61.04 Million CAD | -20.59% |
| 2018 | -50.62 Million CAD | -205.25% |
| 2017 | -16.58 Million CAD | -4514.41% |
| 2016 | -359.4 Thousand CAD | -980.44% |
| 2015 | 40.82 Thousand CAD | -12.11% |
| 2014 | 46.44 Thousand CAD | -42.88% |
| 2013 | 81.31 Thousand CAD | -41.12% |
| 2012 | 138.1 Thousand CAD | 19.6% |
| 2011 | 115.47 Thousand CAD | -3.5% |
| 2010 | 119.65 Thousand CAD | 17.95% |
| 2009 | 101.44 Thousand CAD | 414.4% |
| 2008 | -32.26 Thousand CAD | -316.69% |
| 2007 | 14.89 Thousand CAD | -99.73% |
| 2006 | 5.47 Million CAD | 8.95% |
| 2005 | 5.02 Million CAD | 84.72% |
| 2004 | 2.72 Million CAD | 112.84% |
| 2003 | 1.27 Million CAD | -8.27% |
| 2002 | 1.39 Million CAD | -24.69% |
| 2001 | 1.85 Million CAD | -17.16% |
| 2000 | 2.23 Million CAD | 933.16% |
| 1999 | -268.16 Thousand CAD | -230.22% |
| 1998 | 205.92 Thousand CAD | 1080.09% |
| 1997 | 17.45 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -5.1 Million CAD | 54.92% |
| 2024 Q2 | -3.96 Million CAD | 216.02% |
| 2023 Q3 | -7.93 Million CAD | -65.44% |
| 2023 FY | -42.15 Million CAD | 9.91% |
| 2023 Q4 | -11.31 Million CAD | -42.57% |
| 2023 Q1 | -4.35 Million CAD | 56.57% |
| 2023 Q2 | -4.79 Million CAD | -10.23% |
| 2022 FY | -46.79 Million CAD | -11.39% |
| 2022 Q4 | -10.02 Million CAD | 24.31% |
| 2022 Q3 | -13.23 Million CAD | -34.42% |
| 2022 Q1 | -13.68 Million CAD | 2.43% |
| 2022 Q2 | -9.84 Million CAD | 28.05% |
| 2021 Q3 | -9.12 Million CAD | -45.84% |
| 2021 Q1 | -9.58 Million CAD | 7.71% |
| 2021 Q4 | -14.02 Million CAD | -53.68% |
| 2021 FY | -42 Million CAD | 22.25% |
| 2021 Q2 | -6.25 Million CAD | 34.7% |
| 2020 Q1 | -13.63 Million CAD | 26.85% |
| 2020 FY | -54.03 Million CAD | 11.49% |
| 2020 Q2 | -13.29 Million CAD | 2.44% |
| 2020 Q4 | -10.38 Million CAD | -6.14% |
| 2020 Q3 | -9.78 Million CAD | 26.42% |
| 2019 Q1 | -12.19 Million CAD | 26.14% |
| 2019 FY | -61.04 Million CAD | -20.59% |
| 2019 Q2 | -12.47 Million CAD | -2.29% |
| 2019 Q3 | -19.27 Million CAD | -54.51% |
| 2019 Q4 | -18.63 Million CAD | 3.32% |
| 2018 Q1 | -7.18 Million CAD | 17.92% |
| 2018 Q4 | -16.51 Million CAD | -550466.67% |
| 2018 FY | -50.62 Million CAD | -205.25% |
| 2018 Q2 | -10.33 Million CAD | -43.78% |
| 2018 Q3 | 3000.00 CAD | 100.03% |
| 2017 FY | -16.58 Million CAD | -4514.41% |
| 2017 Q2 | -1.54 Million CAD | -204.23% |
| 2017 Q3 | 4.78 Million CAD | 409.03% |
| 2017 Q1 | 1.48 Million CAD | 351.06% |
| 2017 Q4 | -8.75 Million CAD | -283.07% |
| 2016 Q2 | 9640.00 CAD | 1779.14% |
| 2016 Q4 | 329.25 Thousand CAD | 1546.18% |
| 2016 Q1 | 513.00 CAD | 114.13% |
| 2016 FY | -359.4 Thousand CAD | -980.44% |
| 2016 Q3 | 20 Thousand CAD | 107.48% |
| 2015 Q3 | 13.42 Thousand CAD | -41.14% |
| 2015 FY | 40.82 Thousand CAD | -12.11% |
| 2015 Q1 | 8219.00 CAD | -68.8% |
| 2015 Q2 | 22.8 Thousand CAD | 177.5% |
| 2015 Q4 | -3631.00 CAD | -127.05% |
| 2014 Q4 | 26.33 Thousand CAD | 122.29% |
| 2014 FY | 46.44 Thousand CAD | -42.88% |
| 2014 Q2 | 5818.00 CAD | 138.74% |
| 2014 Q1 | 2437.00 CAD | -82.86% |
| 2014 Q3 | 11.84 Thousand CAD | 103.66% |
| 2013 Q4 | 14.21 Thousand CAD | -30.92% |
| 2013 FY | 81.31 Thousand CAD | -41.12% |
| 2013 Q3 | 20.58 Thousand CAD | -22.1% |
| 2013 Q2 | 26.42 Thousand CAD | 31.5% |
| 2013 Q1 | 20.09 Thousand CAD | -54.37% |
| 2012 Q2 | 33.09 Thousand CAD | 8.59% |
| 2012 Q3 | 30.49 Thousand CAD | -7.86% |
| 2012 Q4 | 44.03 Thousand CAD | 44.41% |
| 2012 FY | 138.1 Thousand CAD | 19.6% |
| 2012 Q1 | 30.47 Thousand CAD | -35.11% |
| 2011 Q4 | 46.96 Thousand CAD | 89.05% |
| 2011 Q3 | 24.84 Thousand CAD | 7.08% |
| 2011 Q2 | 23.2 Thousand CAD | 13.42% |
| 2011 Q1 | 20.45 Thousand CAD | -38.51% |
| 2011 FY | 115.47 Thousand CAD | -3.5% |
| 2010 Q3 | 20.47 Thousand CAD | -56.55% |
| 2010 FY | 119.65 Thousand CAD | 17.95% |
| 2010 Q4 | 33.26 Thousand CAD | 62.51% |
| 2010 Q2 | 47.11 Thousand CAD | 82.56% |
| 2010 Q1 | 25.8 Thousand CAD | -25.64% |
| 2009 Q2 | 14.57 Thousand CAD | -13.71% |
| 2009 Q4 | 34.7 Thousand CAD | -1.64% |
| 2009 Q3 | 35.28 Thousand CAD | 142.12% |
| 2009 FY | 101.44 Thousand CAD | 414.4% |
| 2009 Q1 | 16.88 Thousand CAD | 145.49% |
| 2008 FY | -32.26 Thousand CAD | -316.69% |
| 2008 Q4 | -37.12 Thousand CAD | -254.85% |
| 2008 Q1 | 17.21 Thousand CAD | 100.3% |
| 2008 Q2 | 1905.00 CAD | -88.93% |
| 2008 Q3 | 23.97 Thousand CAD | 1158.48% |
| 2007 FY | 14.89 Thousand CAD | -99.73% |
| 2007 Q4 | -5.66 Million CAD | -316.29% |
| 2007 Q3 | 2.62 Million CAD | 70.56% |
| 2007 Q2 | 1.53 Million CAD | 0.7% |
| 2007 Q1 | 1.52 Million CAD | 615.12% |
| 2006 FY | 5.47 Million CAD | 8.95% |
| 2006 Q1 | 1.51 Million CAD | -26.76% |
| 2006 Q4 | 213.33 Thousand CAD | -90.92% |
| 2006 Q2 | 1.39 Million CAD | -7.95% |
| 2006 Q3 | 2.34 Million CAD | 68.11% |
| 2005 Q4 | 2.07 Million CAD | 105.97% |
| 2005 FY | 5.02 Million CAD | 84.72% |
| 2005 Q1 | 908.57 Thousand CAD | -17.07% |
| 2005 Q3 | 1 Million CAD | -3.24% |
| 2005 Q2 | 1.03 Million CAD | 14.45% |
| 2004 Q3 | 620.05 Thousand CAD | -4.64% |
| 2004 FY | 2.72 Million CAD | 112.84% |
| 2004 Q1 | 346.89 Thousand CAD | -51.89% |
| 2004 Q2 | 650.24 Thousand CAD | 87.44% |
| 2004 Q4 | 1.09 Million CAD | 76.69% |
| 2003 Q4 | 721.03 Thousand CAD | 273.48% |
| 2003 Q3 | 193.05 Thousand CAD | 122.19% |
| 2003 Q2 | 86.88 Thousand CAD | -68.7% |
| 2003 Q1 | 277.63 Thousand CAD | -77.97% |
| 2003 FY | 1.27 Million CAD | -8.27% |
| 2002 FY | 1.39 Million CAD | -24.69% |
| 2002 Q3 | 420.8 Thousand CAD | 48.51% |
| 2002 Q4 | 1.26 Million CAD | 199.43% |
| 2002 Q1 | 256.5 Thousand CAD | -84.68% |
| 2002 Q2 | 283.35 Thousand CAD | 10.47% |
| 2001 Q1 | 282.12 Thousand CAD | -85.92% |
| 2001 Q3 | 32.91 Thousand CAD | -33.01% |
| 2001 Q2 | 49.13 Thousand CAD | -82.58% |
| 2001 Q4 | 1.67 Million CAD | 4987.6% |
| 2001 FY | 1.85 Million CAD | -17.16% |
| 2000 Q2 | -36.83 Thousand CAD | -169.8% |
| 2000 Q1 | 52.76 Thousand CAD | 133.26% |
| 2000 FY | 2.23 Million CAD | 933.16% |
| 2000 Q3 | 140.74 Thousand CAD | 482.13% |
| 2000 Q4 | 2 Million CAD | 1323.82% |
| 1999 FY | -268.16 Thousand CAD | -230.22% |
| 1999 Q1 | 14.77 Thousand CAD | 0.0% |
| 1999 Q4 | -158.66 Thousand CAD | -622.0% |
| 1999 Q2 | -64.33 Thousand CAD | -535.51% |
| 1999 Q3 | 30.39 Thousand CAD | 147.25% |
| 1998 Q1 | 22.79 Thousand CAD | -8.29% |
| 1998 Q2 | 74.91 Thousand CAD | 228.6% |
| 1998 FY | 205.92 Thousand CAD | 1080.09% |
| 1997 FY | 17.45 Thousand CAD | 0.0% |
| 1997 Q4 | 24.85 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -46.45 Million CAD | 59.088% |
| Avicanna Inc. | -7.93 Million CAD | -139.569% |
| Avant Brands Inc. | -1.45 Million CAD | -1209.786% |
| Cardiol Therapeutics Inc. | -29.78 Million CAD | 36.194% |
| Crescita Therapeutics Inc. | -1.95 Million CAD | -871.626% |
| Knight Therapeutics Inc. | -2.89 Million CAD | -557.612% |
| MediPharm Labs Corp. | -18.25 Million CAD | -4.126% |
| OrganiGram Holdings Inc. | -242.73 Million CAD | 92.171% |
| Canopy Growth Corporation | -228.71 Million CAD | 91.69% |
| Willow Biosciences Inc. | -13.18 Million CAD | -44.174% |